Learn Why The Bull Case For Omeros (OMER) Could Change Following EU Drug SetbackSimplywall·Nov 14, 2026 at 04:51 AMOMER-2.78%
Is Omeros (OMER) Undervalued Following Its November 16 Results Catalyst?Simplywall·Nov 11, 2026 at 11:31 AMOMER-2.78%
Omeros (OMER) Stock Dropped, So What Is Driving Attention Now?Simplywall·Nov 2, 2026 at 09:08 AMOMER-2.78%
Omeros Grants CEO Demopulos Performance-Based Options for Up to 500,000 SharesPUBT·Oct 30, 2026 at 09:02 PMOMER-2.78%
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMERprnewswire·Oct 29, 2026 at 01:51 PMOMER-2.78%
Treasury Volatility Spurs Sector-Specific Playbooks: E-Commerce, Biotech and Crypto AdaptGlobal Report·Oct 20, 2026 at 09:17 AMOMER-2.78%KMTS+0.07%
Why Omeros Stock Is Down 13.8% And What's Next After EU Drug RejectionSimplywall·Oct 18, 2026 at 03:23 PMOMER-2.78%
Is Omeros (OMER) Undervalued After The EMA Upheld Its Narsoplimab Setback?Simplywall·Oct 17, 2026 at 11:19 AMOMER-2.78%
Truist Financial, Regions Financial And Other Big Stocks Moving Lower In Friday’s Pre-Market Sessionbenzinga_article·Oct 16, 2026 at 12:02 PMACRS-2.00%CAI-3.84%
Omeros Stock Sinks on Negative EU Opinion for Narsoplimab, Compassionate-Use Program Endsbenzinga_article·Oct 16, 2026 at 10:55 AMOMER-2.78%
